Urologie nieuws
- New urine-based test detects high-grade prostate cancer, helping men avoid unnecessary biopsies
- Association of Elevated C-Reactive Protein with Worsened Outcomes in Different Histologies of Renal Cortical Tumors: Analysis of the INMARC Registry
- FOXA1 regulates ribosomal RNA transcription in prostate cancer
- Cover Image, Volume 43, Number 4, April 2024
- Intra/inter?observer reliability of cystoscopic sphincter evaluation in men undergoing sling surgery
- Initial outcomes and surgical techniques of prostatic urethral lift for benign prostatic hyperplasia in Japan
- Transrectal prostate biopsy: easy, effective and safe
- Population?based study of disease trajectory after radical treatment for high?risk prostate cancer
- Comment on: “Initial Postoperative Prostate Specific Antigen and PSA Velocity Are Important Indicators of Underlying Malignancy After Simple Prostatectomy” by Livingston et al.
- Front-Line Therapeutic Strategy in Metastatic Hormone Sensitive Prostate Cancer: an Updated Therapeutic Algorithm
- Nutcracker Therapeutics displays mRNA drug candidate for prostate cancer, NTX?470 at 2024 AACR annual meeting
- Arvinas enters exclusive strategic license agreement with Novartis to develop & commercialize PROTAC AR degrader, ARV─766 to treat prostate cancer
- Co?targeting SKP2 and KDM5B inhibits prostate cancer progression by abrogating AKT signaling with induction of senescence and apoptosis
- Systematic review and network meta?analysis of re?intervention rates of new surgical interventions for benign prostatic hyperplasia
- Forthcoming Issues
09-04-2024
